Postbiotics in Human Health: A New Frontier in Microbiome Science

As scientific understanding of the human microbiome deepens, the landscape of gut and immune health solutions continues to evolve. While probiotics and prebiotics have long been the focus of microbiome-targeted interventions, a third category—postbiotics—is gaining traction for its unique properties and potential health applications.

Unlike probiotics, which require viability to exert their effects, postbiotics are heat-inactivated or otherwise non-living microbial cells that retain bioactivity. This distinction opens new possibilities for formulation, stability, and regulatory positioning, particularly in markets where live microbial products face logistical or legal constraints.

Promising applications for immune health

One of the most studied applications of postbiotics is in immune health. Research has shown that certain heat-inactivated bacterial strains can interact with the gut-associated lymphoid tissue (GALT), influencing both innate and adaptive immune responses. For example, some postbiotics have been found to activate plasmacytoid dendritic cells (pDCs), which play a central role in orchestrating immune defense mechanisms[RM1] (5,7). This mode of action is distinct from that of many probiotics, which often target a narrower range of immune pathways.

Clinical studies have supported the potential of postbiotics to reduce the incidence and severity of upper respiratory tract infections(5), modulate immune markers such as secretory IgA, and enhance the activity of immune cells like neutrophils(4)[RM2] . These effects have been observed in various populations, including healthy adults and athletes—groups that often seek immune support through dietary supplements. Beyond immunity, emerging evidence suggests that postbiotics may also influence other aspects of health, including skin microbiome balance and gut barrier integrity(9,10).

A practical and versatile solution

The non-viable nature of postbiotics makes them particularly attractive for use in a wide range of delivery formats, from capsules and tablets to powders, gummies, and functional food and beverages. This versatility, combined with long shelf life and ease of handling, makes postbiotics a practical option for product developers.

A growing opportunity in the market

From a market perspective, interest in biotics is growing rapidly. Consumer awareness of the microbiome and its connection to overall health has increased significantly. [RM3]  According to recent surveys, 73%of global consumers say that they recognize the link between digestive health and immune health and many are actively seeking products that support these functions(2). The global postbiotic market is projected to reach $3 billion by 2031, reflecting a compound annual growth rate of nearly 7%(1).

For companies operating in the health and wellness space, postbiotics represent a promising addition to the microbiome toolkit. They offer a science-backed, shelf-stable alternative or complement to probiotics, with potential applications across immunity, digestion, and beyond. As research continues to uncover their mechanisms and benefits, postbiotics are poised to play an increasingly important role in the development of next-generation health products.

Ask us about Immuse the most documented postbiotic for immune health.
 
References
1. Allied Market Research, “Postbiotic Market Size, Share, Competitive Landscape and Trend Analysis Report by Form, by Application: Global Opportunity Analysis and Industry Forecast, 2021-2031,” December 2022.
2. The Impact of Immune Health in the Post-Pandemic Environment on Consumer Behavior, FMCG gurus, September 2022, study in over 30 countries.
3. Shibata, 2016. Journal of Functional Foods 24:492-500.
4. Fujii, 2017. Journal of Functional Foods 35:513-521.
5. Suzuki, 2015. Japanese Pharmacology and Therapeutics, 43, 1465-1472.
6. Khor, 2021. Nutrients, 13(12), 4507.
7. Komano, 2018. Journal of the International Society of Sports Nutrition 15-39.
8. Komano, 2023. Nutrients, 15(7), 1754.
9. Tsuji, 2021. Microorganisms, 9, 563.
10. Fujii, 2021. Microorganisms, 9, 20293.